Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy

Fig. 6

a Invasive ductal carcinoma shows no expression of TFF3 in pre-neoadjuvant breast biopsy b Complete response to neoadjuvant therapy with no residual tumor. c Invasive ductal carcinoma shows mild expression of TFF3 (arrowhead) in pre-neoadjuvant breast biopsy d Complete response to neoadjuvant therapy with no residual tumor. e Invasive ductal carcinoma shows moderate expression of TFF3 (arrowhead) in pre-neoadjuvant breast biopsy. f Incomplete response to neoadjuvant therapy with marked residual malignant cells expressing TFF3 (arrowhead). g Invasive ductal carcinoma shows high expression of TFF3 (arrowhead) in pre-neoadjuvant breast biopsy. h Incomplete response to neoadjuvant therapy with marked residual malignant cells showing high expression of TFF3 (arrowhead)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us